A study evaluating efficacy of bevacizumab combination therapy in advanced colorectal cancer patients.
Phase of Trial: Phase IV
Latest Information Update: 17 Apr 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 17 Apr 2017 Status changed from completed to recruiting.
- 17 Apr 2017 New trial record